Gsa Capital Partners LLP Artivion, Inc. Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	SELL	$12.33 - $18.83 $604,379 - $922,990	-49,017 Reduced 59.45%	33,432 $597,000
Q3 2023 Nov 15, 2023	BUY	$14.82 - $17.52 $796,915 - $942,102	53,773 Added 187.52%	82,449 $1.25 Million
Q2 2023 Aug 14, 2023	SELL	$12.78 - $17.23 $14,121 - $19,039	-1,105 Reduced 3.71%	28,676 $492,000
Q1 2023 May 12, 2023	BUY	$11.74 - $14.12 $20,169 - $24,258	1,718 Added 6.12%	29,781 $390,000
Q4 2022 Feb 13, 2023	BUY	$10.01 - $13.9 $48,138 - $66,845	4,809 Added 20.68%	28,063 $340,000
Q3 2022 Nov 14, 2022	SELL	$13.31 - $23.25 $89,589 - $156,495	-6,731 Reduced 22.45%	23,254 $322,000
Q2 2022 Aug 09, 2022	SELL	$15.73 - $22.91 $1.17 Million - $1.7 Million	-74,163 Reduced 71.21%	29,985 $566,000
Q1 2022 May 11, 2022	BUY	$16.95 - $21.74 $1.77 Million - $2.26 Million	104,148 New	104,148 $2.23 Million
Q4 2021 Feb 14, 2022	SELL	$17.19 - $22.84 $266,651 - $354,294	-15,512 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$22.29 - $28.7 $345,762 - $445,194	15,512 New	15,512 $346,000
Q4 2019 Feb 12, 2020	SELL	$22.45 - $27.09 $333,472 - $402,394	-14,854 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$25.98 - $30.8 $385,906 - $457,503	14,854 New	14,854 $403,000
Q1 2018 May 11, 2018	SELL	$16.85 - $22.1 $204,592 - $268,338	-12,142 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$18.65 - $23.85 $548,589 - $701,547	-29,415 Reduced 70.78%	12,142 $233,000
Q3 2017 Nov 20, 2017	BUY	$18.85 - $23.05 $783,349 - $957,888	41,557	41,557 $943,000

178

36.1M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.25B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.